Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):361-3. doi: 10.1016/j.jaip.2015.10.020. Epub 2015 Dec 24.

Authors

Irina Bobolea¹, Consuelo Fernández Rodriguez², Rocio Diaz-Campos³, Carlos Melero-Moreno³, Ramón Vives-Conesa²

Affiliations

¹ Allergy Department, Hospital 12 de octubre, Institute for Health Research (i+12), Madrid, Spain. Electronic address: ibobolea@gmail.com.
² Allergy Department, Hospital 12 de octubre, Institute for Health Research (i+12), Madrid, Spain.
³ Pulmonology Department, Hospital 12 de octubre, Institute for Health Research (i+12), Madrid, Spain.

PMID: 26725156
DOI: 10.1016/j.jaip.2015.10.020

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aspergillosis, Allergic Bronchopulmonary / diagnosis*
Aspergillosis, Allergic Bronchopulmonary / drug therapy
Disease Progression
Female
Humans
Immunoglobulin E / immunology*
Male
Middle Aged
Omalizumab / therapeutic use

Substances

Omalizumab
Immunoglobulin E